Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $15.42 HKD
Change Today -0.14 / -0.90%
Volume 6.0K
8058 On Other Exchanges
Symbol
Exchange
Hong Kong
OTC US
OTC US
As of 10:35 PM 05/4/15 All times are local (Market data is delayed by at least 15 minutes).

shandong luoxin pharmaceut-h (8058) Snapshot

Open
$15.56
Previous Close
$15.56
Day High
$15.56
Day Low
$15.42
52 Week High
11/14/14 - $18.38
52 Week Low
05/9/14 - $8.65
Market Cap
9.4B
Average Volume 10 Days
403.2K
EPS TTM
$0.73
Shares Outstanding
164.6M
EX-Date
06/10/15
P/E TM
17.0x
Dividend
$0.30
Dividend Yield
2.41%
Current Stock Chart for SHANDONG LUOXIN PHARMACEUT-H (8058)

Related News

No related news articles were found.

shandong luoxin pharmaceut-h (8058) Related Businessweek News

No Related Businessweek News Found

shandong luoxin pharmaceut-h (8058) Details

Shandong Luoxin Pharmaceutical Group Stock Co., Ltd. engages in the manufacture and sale of pharmaceutical products in the People’s Republic of China. It is also involved in the manufacture and wholesale of biochemical products and Chinese medicine. The company was formerly known as Shandong Luoxin Pharmacy Stock Co., Ltd. and changed its name to Shandong Luoxin Pharmaceutical Group Stock Co., Ltd. in August 2014. The company was founded in 1995 and is based in Linyi, the People’s Republic of China. Shandong Luoxin Pharmaceutical Group Stock Co., Ltd. is a subsidiary of Shandong Luoxin Holdings Co., Ltd.

Founded in 1995

shandong luoxin pharmaceut-h (8058) Top Compensated Officers

Chief Executive Officer, Head of Research & D...
Total Annual Compensation: CNY120.0K
Executive Director
Total Annual Compensation: CNY48.0K
Secretary of the Board and Executive Director
Total Annual Compensation: CNY60.0K
Vice General Manager of Production Department...
Total Annual Compensation: CNY60.0K
Manager of Bulk Medicine Workshop and Supervi...
Total Annual Compensation: CNY60.0K
Compensation as of Fiscal Year 2013.

shandong luoxin pharmaceut-h (8058) Key Developments

Luoxin Pharmaceutical Presents at ChinaBio Partnering Forum 2015, Apr-15-2015 02:30 PM

Luoxin Pharmaceutical Presents at ChinaBio Partnering Forum 2015, Apr-15-2015 02:30 PM. Venue: Kerry Hotel, Pudong, Shanghai, China. Speakers: Zhengying Zhu, ­ General Manager and Chief Medical Officer.

Shandong Luoxin Pharmaceutical Group Stock Co., Ltd. Presents at ChinaBio Partnering Forum 2015, Apr-16-2015 10:45 AM

Shandong Luoxin Pharmaceutical Group Stock Co., Ltd. Presents at ChinaBio Partnering Forum 2015, Apr-16-2015 10:45 AM. Venue: Kerry Hotel, Pudong, Shanghai, China.

Shandong Luoxin Pharmaceutical Group Stock Co., Ltd. Reports Consolidated Cash Flow Results for the Year Ended December 31, 2014

Shandong Luoxin Pharmaceutical Group Stock Co., Ltd. reported consolidated cash flow results for the year ended December 31, 2014. For the year, net cash generated from operating activities was RMB 423,681,000 against RMB 79,452,000 a year ago. Purchase of property, plant and equipment was RMB 66,373,000 against RMB 82,093,000 a year ago.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
8058:HK $15.42 HKD -0.14

8058 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 8058.
View Industry Companies
 

Industry Analysis

8058

Industry Average

Valuation 8058 Industry Range
Price/Earnings 17.1x
Price/Sales 2.7x
Price/Book 3.2x
Price/Cash Flow 17.1x
TEV/Sales 2.2x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SHANDONG LUOXIN PHARMACEUT-H, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.